Tracking age-related macular degeneration over time
Part of Eyes & vision clinical trials.
This study observes how dry age-related macular degeneration (AMD) progresses over time. It helps doctors learn more about the disease, which may lead to better treatments in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 85 years old.
- You have dry age-related macular degeneration (AMD) in the early, intermediate, or late stage.
- Your eyes are healthy enough for the study eye exams (no other eye diseases that could interfere).
- You have not had cataract surgery in the last 3 months.
- You do not have high myopia (severe nearsightedness) or abnormal blood vessel growth in the back of the eye (CNV).
- You are not taking long-term medications that could harm your retina or nerves.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called SCT520FF for people with wet age-related macular degeneration (nAMD). It aims to find the safest dose and check if it can improve vision. You may be eligible if you have active new blood vessels in your eye from nAMD and have not had certain other eye problems.
This study tracks how age-related macular degeneration (AMD) progresses over time and looks at factors that might affect your vision and quality of life. By participating, you'll help researchers understand more about AMD and what might predict better or worse outcomes.
This study looks closely at how age-related macular degeneration (AMD) develops and changes over time by taking detailed eye measurements. It may help researchers better understand disease progression, especially for people who already have AMD.
This study uses eye imaging and other tests to predict if early age-related macular degeneration (AMD) will progress to a more advanced stage. It aims to help doctors identify who might need closer monitoring in the future.
This study looks at how age-related macular degeneration (AMD) affects the light-sensitive part of the eye (retina) and the brain. By joining, you help researchers learn more about the condition, which could lead to better treatments in the future.
This study uses special eye scans and tests to look for blood vessel problems that may be linked to dry age-related macular degeneration (AMD). It might help find new ways to treat the condition.
Hear when a new Dry Age-related Macular Degeneration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.